BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12016164)

  • 1. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats.
    Oyama K; Shiota G; Ito H; Murawaki Y; Kawasaki H
    Carcinogenesis; 2002 May; 23(5):885-92. PubMed ID: 12016164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of Bcl-x protein during hepatocarcinogenesis induced exogenously and endogenously in rats.
    Hatanaka Y; Nakae D; Mutai M; Hashizume K; Kamihara Y; Kinoshita N; Tani Y; Danno Gi G; Ohta S; Konishi Y; Ashida H
    Jpn J Cancer Res; 2001 Dec; 92(12):1270-7. PubMed ID: 11749691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid induces apoptosis of hepatocellular carcinoma cells in vitro.
    Zhu L; Shan LJ; Liu YJ; Chen D; Xiao XG; Li Y
    J Dig Dis; 2014 Dec; 15(12):684-93. PubMed ID: 25214410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice.
    Liu H; Xu HW; Zhang YZ; Huang Y; Han GQ; Liang TJ; Wei LL; Qin CY; Qin CK
    World J Gastroenterol; 2015 Sep; 21(36):10367-74. PubMed ID: 26420963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
    Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
    Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats.
    Nagahara T; Okano J; Fujise Y; Abe R; Murawaki Y
    Biomed Pharmacother; 2010 May; 64(5):319-26. PubMed ID: 20434301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.
    Rodrigues CM; Fan G; Wong PY; Kren BT; Steer CJ
    Mol Med; 1998 Mar; 4(3):165-78. PubMed ID: 9562975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines.
    Liu H; Qin CY; Han GQ; Xu HW; Meng M; Yang Z
    World J Gastroenterol; 2007 Mar; 13(11):1652-8. PubMed ID: 17461466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression.
    Kinoshita A; Wanibuchi H; Morimura K; Wei M; Shen J; Imaoka S; Funae Y; Fukushima S
    Carcinogenesis; 2003 Aug; 24(8):1389-99. PubMed ID: 12807726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats.
    Kim DJ; Lee KK; Han BS; Ahn B; Bae JH; Jang JJ
    Jpn J Cancer Res; 1994 Jun; 85(6):578-83. PubMed ID: 8063610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Effect of Ursodeoxycholic Acid in Human Oral Squamous Carcinoma HSC-3 Cells through the Caspases.
    Pang L; Zhao X; Liu W; Deng J; Tan X; Qiu L
    Nutrients; 2015 May; 7(5):3200-18. PubMed ID: 25951128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic Acid (UDCA) Reduces Hepatocyte Apoptosis by Inhibiting Farnesoid X Receptor (FXR) in Hemorrhagic Shock (HS).
    Wang L; Rui X; He HW; Zhou X; Long Y
    Curr Mol Med; 2023; 23(6):550-558. PubMed ID: 35619282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation.
    Rodrigues CM; Ma X; Linehan-Stieers C; Fan G; Kren BT; Steer CJ
    Cell Death Differ; 1999 Sep; 6(9):842-54. PubMed ID: 10510466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid reduces the systemic toxicity of 1,2-dichloro,4-nitrobenzene by stimulating hepatic glutathione S-transferase in mice.
    Kitani K; Kanai S; Sato Y; Ohta M; Nokubo M
    Life Sci; 1994; 54(14):983-9. PubMed ID: 8139388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ursodeoxycholic acid inhibits hepatocyte-like cell apoptosis by down-regulating the expressions of Bax and Caspase-3].
    Ji WJ; Qu Q; Jin Y; Zhao L; He XD
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2997-3001. PubMed ID: 20137712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary supplementation of the citrus antioxidant auraptene inhibits N,N-diethylnitrosamine-induced rat hepatocarcinogenesis.
    Sakata K; Hara A; Hirose Y; Yamada Y; Kuno T; Katayama M; Yoshida K; Zheng Q; Murakami A; Ohigashi H; Ikemoto K; Koshimizu K; Tanaka T; Mori H
    Oncology; 2004; 66(3):244-52. PubMed ID: 15218316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of hepatocarcinogenesis initiated with diethylnitrosamine or N-nitrosobis(2-hydroxypropyl)amine by a choline-deficient, L-amino acid-defined diet administered prior to the carcinogen exposure in rats.
    Kishida H; Nakae D; Kobayashi Y; Kusuoka O; Kitayama W; Denda A; Fukui H; Konishi Y
    Exp Toxicol Pathol; 2000 Oct; 52(5):405-12. PubMed ID: 11089891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of diethylnitrosamine-initiated placental glutathione S-transferase positive preneoplastic and neoplastic lesions by clofibrate, a hepatic peroxisome proliferator.
    Hosokawa S; Tatematsu M; Aoki T; Nakanowatari J; Igarashi T; Ito N
    Carcinogenesis; 1989 Dec; 10(12):2237-41. PubMed ID: 2686852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of cholic acid promotes growth of liver tumors initiated by diethylnitrosamine in rats.
    Shiota G; Oyama K; Noguchi N; Takano T; Ito H; Kawasaki H
    Int J Oncol; 1999 Aug; 15(2):259-65. PubMed ID: 10402235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.